JP2010522600A - 加速度センサによって測定される患者の活動状態に基づく薬剤投与 - Google Patents
加速度センサによって測定される患者の活動状態に基づく薬剤投与 Download PDFInfo
- Publication number
- JP2010522600A JP2010522600A JP2010500403A JP2010500403A JP2010522600A JP 2010522600 A JP2010522600 A JP 2010522600A JP 2010500403 A JP2010500403 A JP 2010500403A JP 2010500403 A JP2010500403 A JP 2010500403A JP 2010522600 A JP2010522600 A JP 2010522600A
- Authority
- JP
- Japan
- Prior art keywords
- patient
- drug delivery
- drug
- control unit
- delivery device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 40
- 238000001647 drug administration Methods 0.000 title description 5
- 238000012377 drug delivery Methods 0.000 claims abstract description 84
- 239000003814 drug Substances 0.000 claims abstract description 54
- 229940079593 drug Drugs 0.000 claims abstract description 52
- 230000001133 acceleration Effects 0.000 claims abstract description 39
- 230000008878 coupling Effects 0.000 claims abstract description 4
- 238000010168 coupling process Methods 0.000 claims abstract description 4
- 238000005859 coupling reaction Methods 0.000 claims abstract description 4
- 238000005259 measurement Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 238000004891 communication Methods 0.000 claims description 11
- 210000004243 sweat Anatomy 0.000 claims description 2
- 230000033001 locomotion Effects 0.000 abstract description 44
- 208000018737 Parkinson disease Diseases 0.000 abstract description 24
- 201000010099 disease Diseases 0.000 abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 21
- 238000011282 treatment Methods 0.000 abstract description 19
- 238000012544 monitoring process Methods 0.000 abstract description 8
- 230000009467 reduction Effects 0.000 abstract description 5
- 206010044565 Tremor Diseases 0.000 description 16
- 230000008901 benefit Effects 0.000 description 16
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 238000007726 management method Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000036757 core body temperature Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 208000018883 loss of balance Diseases 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 1
- 229940098778 Dopamine receptor agonist Drugs 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000005358 geomagnetic field Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000009115 maintenance therapy Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000009117 preventive therapy Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/63—Motion, e.g. physical activity
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
112 モーションセンシングユニット/3D加速度センサ
113 (有線又は無線の)データ接続
120 制御ユニット/処理及び通信ユニット
122 (有線又は無線の)制御線
125 入力装置
126 出力装置
150 ドラッグデリバリ装置
152 フィードバックライン
280 センシングユニット、電源、制御ユニット及び伝送ユニットを含むモジュール
280a モジュール280の断面
285a センシングユニット、電源、制御ユニット、及び伝送ユニットを含むモジュールの断面
390 加速を引き起こす震動の時間依存性を図示する図
391 x軸方向の加速の振幅
392 加速の振幅の絶対値
395 x軸方向の加速391のフーリエ変換を図示する図
450 ドラッグデリバリ装置/マイクロジェット装置
453 マイクロジェットインジェクタ
454 皮膚接触センサ
455 USBポート
456 温度センサ
458 刺激センサ
459 ストラップ
459a 固着手段/ベルクロファスナ
512 モーションセンシング装置/3D姿勢センサ/3D加速度センサ
513 無線データ接続
550 ドラッグデリバリ装置/マイクロジェット装置
595 患者
Claims (15)
- 患者の体に少なくとも1つの薬を送達するシステムであって、
前記患者の活動状態を示すパラメータの少なくとも1つの値を測定する測定装置と、
前記測定装置に結合され、前記パラメータの前記値に基づいて制御信号を決定する制御ユニットと、
前記制御ユニットに結合され、前記制御信号に基づいて前記患者の体に少なくとも1つの薬を送達するドラッグデリバリ装置と
を有し、前記測定装置が、複数の加速度センサを有するシステム。 - 前記制御ユニットが、リアルタイムで前記制御信号を決定する、請求項1に記載のシステム。
- 前記制御ユニットが、一日のうちの現在の時刻に基づいて前記制御信号を決定する、請求項1に記載のシステム。
- 前記患者の活動状態を示す、前記パラメータの複数の値を記憶するメモリを更に有し、これらの値が、異なる時刻に取得される、請求項1に記載のシステム。
- 前記加速度センサによって提供される信号の周波数分布を評価するユニットを更に有する、請求項1に記載のシステム。
- 前記測定装置、前記制御ユニット、及び/又は前記ドラッグデリバリ装置が、前記患者の体の外部に機械的に結合されるように設計される、請求項1に記載のシステム。
- 前記測定装置、前記制御ユニット、及び前記ドラッグデリバリ装置の間の結合が、ワイヤレス接続を含む、請求項1に記載のシステム。
- 前記ドラッグデリバリ装置が、前記測定装置及び/又は前記制御ユニットと空間的に分離され得るモジュールによって実現される、請求項1に記載のシステム。
- 前記ドラッグデリバリ装置が、マイクロジェットベースの装置である、請求項1に記載のシステム。
- 前記ドラッグデリバリ装置が、イオン泳動装置である、請求項1に記載のシステム。
- 前記測定装置が、磁場センサを備える、請求項1に記載のシステム。
- 前記測定装置が、皮膚インピーダンスセンサを備える、請求項1に記載のシステム。
- 前記測定装置が、心拍数センサ及び/又は汗センサを備える、請求項1に記載のシステム。
- 前記制御ユニットに結合される通信ユニットを更に有する、請求項1に記載のシステム。
- 患者の体に少なくとも1つの薬を送達させる方法であって、
複数の加速度センサによって、前記患者の活動状態を示すパラメータのうちの少なくとも1つの値を測定するステップと、
前記パラメータの前記値に基づいて制御信号を決定するステップと、
前記制御信号に基づいて前記患者の体に薬を送達させるステップと
を含む方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07105001 | 2007-03-27 | ||
PCT/IB2008/051082 WO2008117226A1 (en) | 2007-03-27 | 2008-03-21 | Drug administration based on a patient's activity status measured by acceleration sensors |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2010522600A true JP2010522600A (ja) | 2010-07-08 |
Family
ID=39473971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010500403A Pending JP2010522600A (ja) | 2007-03-27 | 2008-03-21 | 加速度センサによって測定される患者の活動状態に基づく薬剤投与 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20100106076A1 (ja) |
EP (1) | EP2131894A1 (ja) |
JP (1) | JP2010522600A (ja) |
CN (1) | CN101646470B (ja) |
WO (1) | WO2008117226A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014084441A1 (ko) * | 2012-11-30 | 2014-06-05 | 경희대학교 산학협력단 | 가속도 센서를 이용한 환자분석 장치 및 방법 |
JP2024516734A (ja) * | 2021-05-07 | 2024-04-16 | チェイス,アーノルド | インテリジェント薬剤送達システム |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2037999B1 (en) | 2006-07-07 | 2016-12-28 | Proteus Digital Health, Inc. | Smart parenteral administration system |
JP5243548B2 (ja) | 2007-10-25 | 2013-07-24 | プロテウス デジタル ヘルス, インコーポレイテッド | 情報システムのための流体伝達ポート |
WO2009067463A1 (en) | 2007-11-19 | 2009-05-28 | Proteus Biomedical, Inc. | Body-associated fluid transport structure evaluation devices |
WO2010100883A1 (ja) * | 2009-03-04 | 2010-09-10 | パナソニック株式会社 | 薬剤注入装置 |
US8439896B2 (en) * | 2009-11-13 | 2013-05-14 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
US8894630B2 (en) * | 2009-11-13 | 2014-11-25 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
US8784368B2 (en) * | 2009-11-13 | 2014-07-22 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
US20110173152A1 (en) * | 2010-01-08 | 2011-07-14 | Fundacio Privada Hospital Comarcal De Sant Antoni Abat De Vilanova I La Geltru | Method and device for detecting the On and Off states of a Parkinson patient |
EP2531099B1 (en) | 2010-02-01 | 2018-12-12 | Proteus Digital Health, Inc. | Data gathering system |
WO2011094608A2 (en) | 2010-02-01 | 2011-08-04 | Proteus Biomedical, Inc. | Two-wrist data gathering system |
EP2653179B1 (en) * | 2012-04-17 | 2019-07-10 | Micrel Medical Devices S.A. | System for calculating and administering a drug to a patient with Parkinson's disease |
CN103785105B (zh) * | 2012-10-30 | 2016-08-17 | 苏州景昱医疗器械有限公司 | 一种病人控制器、植入式神经刺激系统及反馈调节方法 |
CN106133521A (zh) * | 2013-10-02 | 2016-11-16 | 苏瑞科技有限公司 | 用于治疗异质肿瘤的病患特异性的免疫疗法 |
CN103984857A (zh) * | 2014-05-08 | 2014-08-13 | 林继先 | 一种帕金森病情监控系统和方法 |
CA2948003C (en) | 2014-06-03 | 2023-06-27 | Amgen Inc. | Drug delivery system and method of use |
AU2016315947B2 (en) | 2015-08-31 | 2021-02-18 | Masimo Corporation | Wireless patient monitoring systems and methods |
US11039986B2 (en) * | 2016-02-25 | 2021-06-22 | Samsung Electronics Co., Ltd. | Chronotherapeutic dosing of medication and medication regimen adherence |
JP2016116948A (ja) * | 2016-03-28 | 2016-06-30 | セイコーエプソン株式会社 | 液体注入システム |
JP7251889B2 (ja) * | 2017-02-01 | 2023-04-04 | 武田薬品工業株式会社 | 生理学的検知及び治療物投与のシステム及び方法 |
CN108245742A (zh) | 2018-01-19 | 2018-07-06 | 苏州英诺迈医学科技服务有限公司 | 一种胰岛素注射装置 |
US11202860B2 (en) * | 2018-06-06 | 2021-12-21 | International Business Machines Corporation | Controlled drug delivery in point-of-care drug delivery system based on real-time monitoring with integrated sensor |
US20200329993A1 (en) | 2019-04-17 | 2020-10-22 | Masimo Corporation | Electrocardiogram device |
USD917704S1 (en) | 2019-08-16 | 2021-04-27 | Masimo Corporation | Patient monitor |
USD919094S1 (en) | 2019-08-16 | 2021-05-11 | Masimo Corporation | Blood pressure device |
USD919100S1 (en) | 2019-08-16 | 2021-05-11 | Masimo Corporation | Holder for a patient monitor |
USD985498S1 (en) | 2019-08-16 | 2023-05-09 | Masimo Corporation | Connector |
USD927699S1 (en) | 2019-10-18 | 2021-08-10 | Masimo Corporation | Electrode pad |
USD933232S1 (en) | 2020-05-11 | 2021-10-12 | Masimo Corporation | Blood pressure monitor |
USD979516S1 (en) | 2020-05-11 | 2023-02-28 | Masimo Corporation | Connector |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001299711A (ja) * | 2000-04-18 | 2001-10-30 | Hiroshi Matsumoto | 生体情報検出装置付機能拡張型ホルター心電計 |
JP2005193026A (ja) * | 2003-12-26 | 2005-07-21 | Codman & Shurtleff Inc | くも膜下カテーテルを介して筋活動を制御するための閉ループ装置および方法 |
US20050177097A1 (en) * | 2004-02-06 | 2005-08-11 | Hildebrand Keith R. | Delivery of a sympatholytic cardiovascular agent to the central nervous system |
JP2006516100A (ja) * | 2002-10-09 | 2006-06-22 | コンピュメディクス・リミテッド | 治療的処置中に睡眠の質を維持し監視する方法および装置 |
WO2006075016A1 (en) * | 2005-01-17 | 2006-07-20 | Novo Nordisk A/S | Fluide delivery device with integrated monitoring of physiological characteristics |
US20060206066A1 (en) * | 2005-03-10 | 2006-09-14 | Bozidar Ferek-Petric | Communications system for an implantable device and a drug dispenser |
JP2008513082A (ja) * | 2004-09-20 | 2008-05-01 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 脳深部刺激システム |
JP2008521566A (ja) * | 2004-12-01 | 2008-06-26 | メドトロニック・インコーポレーテッド | 心膜空間内に治療を提供する方法及びシステム |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6198394B1 (en) * | 1996-12-05 | 2001-03-06 | Stephen C. Jacobsen | System for remote monitoring of personnel |
US6411849B1 (en) * | 1999-12-08 | 2002-06-25 | Pacesetter, Inc. | Implatable electrical device incorporating a magnetoresistive-based motion sensor |
DE10006044A1 (de) * | 2000-02-10 | 2001-08-16 | Roche Diagnostics Gmbh | Anordnung und Verfahren zur Dosierung eines die Blutglukose eines Patienten regulierenden Hormons |
US6969369B2 (en) | 2002-04-22 | 2005-11-29 | Medtronic, Inc. | Implantable drug delivery system responsive to intra-cardiac pressure |
EP1386626A1 (en) | 2002-07-31 | 2004-02-04 | Novo Nordisk A/S | Delivery device for treatment of diabetes mellitus |
US7320675B2 (en) | 2003-08-21 | 2008-01-22 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
US7070568B1 (en) | 2004-03-02 | 2006-07-04 | Pacesetter, Inc. | System and method for diagnosing and tracking congestive heart failure based on the periodicity of Cheyne-Stokes Respiration using an implantable medical device |
-
2008
- 2008-03-21 CN CN2008800102188A patent/CN101646470B/zh not_active Expired - Fee Related
- 2008-03-21 JP JP2010500403A patent/JP2010522600A/ja active Pending
- 2008-03-21 WO PCT/IB2008/051082 patent/WO2008117226A1/en active Application Filing
- 2008-03-21 US US12/593,123 patent/US20100106076A1/en not_active Abandoned
- 2008-03-21 EP EP08719805A patent/EP2131894A1/en not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001299711A (ja) * | 2000-04-18 | 2001-10-30 | Hiroshi Matsumoto | 生体情報検出装置付機能拡張型ホルター心電計 |
JP2006516100A (ja) * | 2002-10-09 | 2006-06-22 | コンピュメディクス・リミテッド | 治療的処置中に睡眠の質を維持し監視する方法および装置 |
JP2005193026A (ja) * | 2003-12-26 | 2005-07-21 | Codman & Shurtleff Inc | くも膜下カテーテルを介して筋活動を制御するための閉ループ装置および方法 |
US20050177097A1 (en) * | 2004-02-06 | 2005-08-11 | Hildebrand Keith R. | Delivery of a sympatholytic cardiovascular agent to the central nervous system |
JP2008513082A (ja) * | 2004-09-20 | 2008-05-01 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 脳深部刺激システム |
JP2008521566A (ja) * | 2004-12-01 | 2008-06-26 | メドトロニック・インコーポレーテッド | 心膜空間内に治療を提供する方法及びシステム |
WO2006075016A1 (en) * | 2005-01-17 | 2006-07-20 | Novo Nordisk A/S | Fluide delivery device with integrated monitoring of physiological characteristics |
US20060206066A1 (en) * | 2005-03-10 | 2006-09-14 | Bozidar Ferek-Petric | Communications system for an implantable device and a drug dispenser |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014084441A1 (ko) * | 2012-11-30 | 2014-06-05 | 경희대학교 산학협력단 | 가속도 센서를 이용한 환자분석 장치 및 방법 |
JP2024516734A (ja) * | 2021-05-07 | 2024-04-16 | チェイス,アーノルド | インテリジェント薬剤送達システム |
Also Published As
Publication number | Publication date |
---|---|
US20100106076A1 (en) | 2010-04-29 |
WO2008117226A1 (en) | 2008-10-02 |
EP2131894A1 (en) | 2009-12-16 |
CN101646470A (zh) | 2010-02-10 |
CN101646470B (zh) | 2012-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010522600A (ja) | 加速度センサによって測定される患者の活動状態に基づく薬剤投与 | |
Sharma et al. | Intelligent automated drug administration and therapy: future of healthcare | |
US8545435B2 (en) | Method and apparatus for providing medical treatment therapy based on calculated demand | |
EP1962686B1 (en) | Wearable ambulatory data recorder | |
EP1841476B1 (en) | Fluid delivery device with integrated monitoring of physiological characteristics | |
EP1732436B1 (en) | Detecting sleep | |
US20100042043A1 (en) | Automatic drug administration with reduced power consumption | |
HK1201145A1 (en) | Methods and devices for treating hypertension | |
WO2011016028A1 (en) | Device, system and method for meal detection for interfacing with and controlling auxiliary devices associated therewith | |
Yadav et al. | E-drug delivery: A futuristic approach | |
US12138413B2 (en) | Optimized intrathecal drug delivery | |
US12102790B2 (en) | Connected drug delivery system for erythropoietin stimulating agents | |
US20240148299A1 (en) | Ingestible anxiety monitoring and treatment system | |
CN116437856A (zh) | 用阻抗测量监测生理参数 | |
CN109414228A (zh) | 用于检测用户体液中的至少一种分析物的传感器设备 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110316 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120824 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120911 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121211 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130718 |